Yasunori Sano

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Diverse tau pathologies in late-life mood disorders revealed by PET and autopsy assays.

Diverse tau pathologies in late-life mood disorders revealed by PET and autopsy assays.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 13, 2025

Alterations of striatal phosphodiesterase 10 A and their association with recurrence rate in bipolar I disorder.

Alterations of striatal phosphodiesterase 10 A and their association with recurrence rate in bipolar I disorder.

Journal: Translational psychiatry

Published: July 23, 2024

In vivo PET classification of tau pathologies in patients with frontotemporal dementia.

In vivo PET classification of tau pathologies in patients with frontotemporal dementia.

Journal: Brain communications

Published: August 23, 2023

Association between mammillary body atrophy and memory impairment in retired athletes with a history of repetitive mild traumatic brain injury.

Association between mammillary body atrophy and memory impairment in retired athletes with a history of repetitive mild traumatic brain injury.

Journal: Scientific reports

Published: June 25, 2023

Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia.

Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia.

Journal: Schizophrenia bulletin

Published: December 02, 2022

Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy.

Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy.

Journal: Journal of the neurological sciences

Published: October 12, 2022

Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management.

Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management.

Journal: Neurology

Published: June 08, 2022

Correction to: First‑in‑human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with 18F‑T‑401.

Correction to: First‑in‑human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with 18F‑T‑401.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 11, 2022

Findings of 18 F-PI-2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P-tau181 levels in a Japanese sample.

Findings of 18 F-PI-2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P-tau181 levels in a Japanese sample.

Journal: Neuropsychopharmacology reports

Published: April 04, 2022

A Machine Learning-Based Approach to Discrimination of Tauopathies Using [18 F]PM-PBB3 PET Images.

A Machine Learning-Based Approach to Discrimination of Tauopathies Using [18 F]PM-PBB3 PET Images.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 07, 2022

An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with 18F-PM-PBB3 (18F-APN-1607).

An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with 18F-PM-PBB3 (18F-APN-1607).

Journal: NeuroImage

Published: February 14, 2022

PET-based classification of corticobasal syndrome.

PET-based classification of corticobasal syndrome.

Journal: Parkinsonism & related disorders

Published: October 20, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026